Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7473.074 | 0.0135 | -0.6339 | 2.5364 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7473.074 | 0.0135 | -0.6339 | 2.5364 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7474.074 | 1.1320 | 1.0969 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7474.074 | 1.1320 | 1.0969 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7474.074 | 1.2410 | 1.1717 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7474.074 | 1.2410 | 1.1717 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7474.074 | 1.0685 | 1.0512 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7474.074 | 1.0685 | 1.0512 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7474.074 | 0.8647 | 0.8921 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7474.074 | 0.8647 | 0.8921 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7474.074 | 0.0082 | -0.6802 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7474.074 | 0.0082 | -0.6802 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7474.074 | 0.0072 | -0.6949 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7474.074 | 0.0072 | -0.6949 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7474.074 | 0.0034 | -0.7702 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7474.074 | 0.0034 | -0.7702 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7474.074 | 0.0128 | -0.6206 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7474.074 | 0.0128 | -0.6206 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7474.074 | 0.0059 | -0.7172 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 167 | uM | 7474.074 | 0.0059 | -0.7172 | 2.6218 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7475.074 | 1.0853 | 1.0671 | 2.4793 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7475.074 | 1.0853 | 1.0671 | 2.4793 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7475.074 | 1.1513 | 1.1170 | 2.4793 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7475.074 | 1.1513 | 1.1170 | 2.4793 | |
| Hs 578T | TNBC | Basal B | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7475.074 | 1.1185 | 1.0924 | 2.4793 |